Co-Diagnostics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Co-Diagnostics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q3 2024.
  • Co-Diagnostics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.2M, a 14.5% decline year-over-year.
  • Co-Diagnostics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$40M, a 29.8% increase year-over-year.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2023 was -$42.7M, a 58.3% decline from 2022.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2022 was -$27M, a 159% decline from 2021.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2021 was $46.1M, a 10.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$40M -$10.2M -$1.3M -14.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$38.7M -$7.68M +$4.31M +36% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$43M -$10.3M -$309K -3.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$42.7M -$11.8M +$14.3M +54.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$57M -$8.94M -$2.4M -36.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$54.6M -$12M -$7.85M -189% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$46.8M -$9.95M -$19.8M -201% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$27M -$26.1M -$36.4M -353% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $9.45M -$6.54M -$20.2M -148% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $29.6M -$4.15M -$15.9M -135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $45.6M $9.82M -$511K -4.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $46.1M $10.3M -$5.72M -35.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $51.8M $13.6M +$1.59M +13.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $50.2M $11.8M -$2.92M -19.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $53.1M $10.3M +$11.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $41.7M $16M +$17.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $24M $12M +$13.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $10.4M $14.7M +$16.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$5.72M -$1.08M +$173K +13.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$5.89M -$1.62M +$200K +11% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$6.09M -$1.65M +$13.7K +0.82% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$6.11M -$1.37M -$12.4K -0.92% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-11-03
Q1 2019 -$6.09M -$1.25M +$22.9K +1.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$6.12M -$1.82M -$330K -22.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$5.79M -$1.66M +$141K +7.83% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$5.93M -$1.35M -$652K -93.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.28M -$1.28M -$713K -126% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$4.56M -$1.49M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$1.81M -$1.41M -360% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$701K -$311K -79.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$564K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$392K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$390K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.